Significance of heterogeneous nuclear ribonucleoprotein B1 as a new early detection marker for oral squamous cell carcinoma

Japanese Journal of Cancer Research

Volumn 90, Issue 12, 1999, Pages 1358-1363

  Goto, Yuri ^a,b   Sueoka, Eisaburo ^a   Chiba, Hiroshige ^b   Fujiki, Hirota ^a  

^a SAITAMA CANCER CENTER   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Biomarker; Chemoprevention; Cytodiagnosis; Oral leukoplakia; Oral precancerous lesion

Indexed keywords

ANTIBODY; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CYTODIAGNOSIS; EARLY DIAGNOSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKOPLAKIA; LUNG SQUAMOUS CELL CARCINOMA; MALE; MOLECULAR WEIGHT; MOUTH CARCINOMA; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STAINING;

EID: 0033382228     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1999.tb00720.x     Document Type: Article

References (17)

1. Sueoka, E., Goto, Y., Sueoka, N., Kai, Y., Kozu, T. and Fujiki, H. Heterogeneous nuclear ribonucleoprotein B1 as a new marker of early detection for human lung cancers. Cancer Res., 59, 1404-1407 (1999).
2. Kozu, T., Henrich, B. and Schäffer, K. P. Structure and expression of the gene (HNRPA2BI) encoding the human hnRNP protein A2/B1. Genomics, 25, 363-371 (1995).
3. Mayeda, A., Munroe, S. H., Cáceres, J. F. and Krainer, A. R. Function of conserved domains of hnRNP A1 and other hnRNP A/B proteins. EMBO J., 13, 5483-5495 (1994).
4. Benchimol, S., Fuks, A., Jothy, S., Beauchemin, N., Shirota, K. and Stanners, C. P. Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell, 57, 327-334 (1989).
5. Fischbach, W., Meyer, T. and Barthel, K. Squamous cell carcinoma antigen in the diagnosis and treatment follow-up oral and facial squamous cell carcinoma. Cancer, 65, 1321-1324 (1990).
6. Hirata, S., Odajima, T., Kohama, G.-I., Ishigaki, S. and Niitsu, Y. Significance of glutathione S-transferase-π as a tumor marker in patients with oral cancer. Cancer, 70, 2381-2387 (1992).
7. Chen, Y. K. and Lin, L. M. Immunohistochemical demonstration of epithelial glutathione S-transferase isoenzymes in normal, benign, premalignant and malignant human oral mucosa. J. Oral Pathol. Med., 24, 316-321 (1995).
8. Kurokawa, H., Tokudome, S., Yamashita, Y., Ishibashi, H., Yoshikawa, T. and Kajiyama, M. Serum fragment of cytokeratin subunit 19 (Cyfra) as a tumor marker in diagnosis and monitoring of treatment of oral squamous cell carcinoma. Int. J. Clin. Oncol., 4, 17-21 (1999).
9. Doweck, I., Barak, M., Greenberg, E., Uri, N., Kellner, J., Lurie, M. and Gruener, N. A new potential tumor marker for squamous cell carcinoma of head and neck. Arch. Otolaryngol. Head Neck Surg., 121, 177-181 (1995).
10. Vitarelli, E., Sippelli, G., Tuccari, G. and Barresi, G. The use of microwave irradiation for immunohistochemistry: a new methodological proposal. Histol. Histopathol., 10, 35-38 (1995).
11. Chomczynski, P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques, 15, 532-534, 536-537 (1993).
12. Karabulut, A., Reibel, J., Therkildsen, M. H., Prætorius, F., Nielsen, H. W. and Dabelsteen, E. Observer variability in the histologic assessment of oral premalignant lesions. J. Oral Pathol. Med., 24, 198-200 (1995).
13. Pindborg, J. J. Oral precancer. In "Surgical Pathology of the Head and Neck," ed. L. Barnes, Vol. 1, pp. 279-331 (1995). Marcel Dekker, Inc., New York and Basel.
14. Sankaranarayanan, R., Mathew, B., Varghese, C., Sudhakaran, P. R., Menon, V., Jayadeep, A., Nair, M. K., Mathews, C., Mahalingam, T. R., Balaram, P. and Nair, P. P. Chemoprevention of oral leukoplakia with vitamin A and β-carotene: an assessment. Oral Oncol., 33, 231-236 (1995).
15. Kelloff, G. J., Boone, C. W., Crowell, J. A., Nayfield, S. G., Hawk, E., Malone, W. F., Steele, V. E., Lubet, R. A. and Sigman, C. C. Risk biomarkers and current strategies for cancer chemoprevention. J. Cell. Biochem., 25S, 1-14 (1996).
16. Tockman, M. S., Gupta, P. K., Myers, J. D., Frost, J. K., Baylin, S. B., Gold, E. B., Chase, A. M., Wilkinson, P. H. and Mulshine, J. L. Sensitive and specific monoclonal antibody recognition of human lung cancer antigen on preserved sputum cells: a new approach to early lung cancer detection. J. Clin. Oncol., 6, 1685-1693 (1988).
17. Tockman, M. S., Mulshine, J. L., Piantadosi, S., Erozan, Y. S., Gupta, P. K., Ruckdeschel, J. C., Taylor, P. R., Zhukov, T., Zhou, W.-H., Qiao, Y.-L. and Yao, S.-X. Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression. Clin. Cancer Res., 3, 2237-2246 (1997).